5Effects of estrogen receptor modulators on cytoskeletal proteins in the central nervous systemINVITED REVIEWS1231-1240
6Transcriptional inhibition in Schwann cell development and nerve regenerationINVITED REVIEWS1241-1246
7LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?INVITED REVIEWS1247-1251
8Modulation of valosin-containing protein by Kyoto University Substances (KUS) as a novel therapeutic strategy for ischemic neuronal diseasesINVITED REVIEWS1252-1255
9Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapyINVITED REVIEWS1256-1261
10Metabolic pathways as possible therapeutic targets for progressive multiple sclerosisINVITED REVIEWS1262-1267
13A role for lipids as agents to alleviate stroke damage: the neuroprotective effect of 2-hydroxy arachidonic acidPERSPECTIVES1273-1275
14Reassembly of the axon initial segment and nodes of Ranvier in regenerated axons of the central nervous systemPERSPECTIVES1276-1277
15Spreading depression and focal venous cerebral ischemia enhance cortical neurogenesisRESEARCH ARTICLES1278-1286
16Extract of Ginkgo biloba promotes neuronal regeneration in the hippocampus after exposure to acrylamideRESEARCH ARTICLES1287-1293
17Cortical activation pattern during shoulder simple versus vibration exercises: a functional near infrared spectroscopy studyRESEARCH ARTICLES1294-1298
18Relationship of nocturnal concentrations of melatonin, gamma-aminobutyric acid and total antioxidants in peripheral blood with insomnia after stroke: study protocol for a prospective non-randomized controlled trialRESEARCH ARTICLES1299-1307
19Xingnao Kaiqiao needling method for acute ischemic stroke: a meta-analysis of safety and efficacyRESEARCH ARTICLES1308-1314
20Association and differences in genetic polymorphisms in PCSK9 gene in subjects with lacunar infarction in the Han and Uygur populations of Xinjiang Uygur Autonomous Region of ChinaRESEARCH ARTICLES1315-1321
